hy p72782 Search Results


cxcl12  (MedChemExpress)
93
MedChemExpress cxcl12
Figure 6. MIF represses adipogenesis and activates ERK1/2 in vitro (A) Representative images of SVF cells and the corresponding culture dishes with oil red O staining. The SVF cells were induced to differentiate into Adi in the absence (control) or presence of MIF, CXCL11, or <t>CXCL12.</t> Scale bar, 100 mm.
Cxcl12, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cxcl12/product/MedChemExpress
Average 93 stars, based on 1 article reviews
cxcl12 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Figure 6. MIF represses adipogenesis and activates ERK1/2 in vitro (A) Representative images of SVF cells and the corresponding culture dishes with oil red O staining. The SVF cells were induced to differentiate into Adi in the absence (control) or presence of MIF, CXCL11, or CXCL12. Scale bar, 100 mm.

Journal: Cell metabolism

Article Title: MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia.

doi: 10.1016/j.cmet.2025.01.018

Figure Lengend Snippet: Figure 6. MIF represses adipogenesis and activates ERK1/2 in vitro (A) Representative images of SVF cells and the corresponding culture dishes with oil red O staining. The SVF cells were induced to differentiate into Adi in the absence (control) or presence of MIF, CXCL11, or CXCL12. Scale bar, 100 mm.

Article Snippet: When the cells reached confluence, differentiation was induced by changing the medium to Induction Medium (DMEM/F-12 containing 10% FBS, 1% P/S, 10 mg/mL insulin, 0.5 mM 3-isobutyl-1methylxantine, 1 mM dexamethasone, 2.5 mM rosiglitazone) and incubated for 2 d. Then the cells were switched to Maintenance Medium (DMEM/F-12 containing 10% FBS, 1%P/S, 10 mg/mL insulin) for 2 d, followed by replacement with fresh MaintenanceMedium and incubated for another 2 d. For the chronic treatment, 5 mg/mL MIF (MedChemExpress, HY-P7388), 1 ng/mL CXCL11 (MedChemExpress, HY-P700169AF), or 0.2 ng/mL CXCL12 (MedChemExpress, HY-P72782) was added into the Induction Medium andMaintenanceMedium throughout the differentiation process.

Techniques: In Vitro, Staining, Control